积日累久——1例特发性颅高压患者的诊疗
|
摘要
<正>特发性颅高压(idiopathic intracranial hypertension, IIH)定义为无脑实质病变、脑室无扩大、无脑内占位及感染,以及无大脑静脉系统疾病导致不明原因的颅内压增高综合征。育龄期女性、体重超标及伴有内分泌失调人群易患。临床特征包括头痛、视物模糊及搏动性耳鸣。眼部体征主要为双侧视乳头水肿。由于中晚期患者来诊时眼底表现不典型而容易漏诊。尽早明确诊断可以保护患者视功能,减少致盲发生。1 病例资料患者女性,
引文
[ 1 ] MARKEY K A,MOLLAN S P,JENSEN R H,et al.Understanding idiopathic intracranial hypertension:mechanisms,management,and future directions[J].Lancet Neurol,2016,15(1):78-91.
[ 2 ] MADRIZ PERALTA G,CESTARI D M.An update of idiopathic intracranial hypertension[J].Curr Opin Ophthalmol,2018,29(6):495-502.
[ 3 ] FRIEDMAN D I,LIU G T,DIGRE K B.Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children[J].Neurology,2013,81(13):1159-1165.
[ 4 ] 田国红.特发性颅内压增高的诊疗流程[J].中国眼耳鼻喉科杂志,2015,15(6):445-448.
[ 5 ] 田国红,陈倩.视盘水肿的鉴别及病因分析[J].中国眼耳鼻喉科杂志,2017,17(5):378-381.
[ 6 ] CHEN Q,CHEN W,WANG M,et al.High-resolution transbulbar ultrasonography helping differentiate intracranial hypertension in bilateral optic disc oedema patients[J].Acta Ophthalmol,2017,95(6):e481-e485.
[ 7 ] SZEWKA A J,BRUCE B B,NEWMAN N J,et al.Idiopathic intracranial hypertension:relation between obesity and visual outcomes[J].J Neuroophthalmol,2013,33(1):4-8.
[ 8 ] TEN HOVE M W,FRIEDMAN D I,PATEL A D,et al.Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial[J].J Neuroophthalmol,2016,36(1):13-19.
[ 9 ] OBI E E,LAKHANI B K,BURNS J,et al.Optic nerve sheath fenestration for idiopathic intracranial hypertension:A seven year review of visual outcomes in a tertiary centre[J].Clin Neurol Neurosurg,2015,137:94-101.
[ 2 ] MADRIZ PERALTA G,CESTARI D M.An update of idiopathic intracranial hypertension[J].Curr Opin Ophthalmol,2018,29(6):495-502.
[ 3 ] FRIEDMAN D I,LIU G T,DIGRE K B.Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children[J].Neurology,2013,81(13):1159-1165.
[ 4 ] 田国红.特发性颅内压增高的诊疗流程[J].中国眼耳鼻喉科杂志,2015,15(6):445-448.
[ 5 ] 田国红,陈倩.视盘水肿的鉴别及病因分析[J].中国眼耳鼻喉科杂志,2017,17(5):378-381.
[ 6 ] CHEN Q,CHEN W,WANG M,et al.High-resolution transbulbar ultrasonography helping differentiate intracranial hypertension in bilateral optic disc oedema patients[J].Acta Ophthalmol,2017,95(6):e481-e485.
[ 7 ] SZEWKA A J,BRUCE B B,NEWMAN N J,et al.Idiopathic intracranial hypertension:relation between obesity and visual outcomes[J].J Neuroophthalmol,2013,33(1):4-8.
[ 8 ] TEN HOVE M W,FRIEDMAN D I,PATEL A D,et al.Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial[J].J Neuroophthalmol,2016,36(1):13-19.
[ 9 ] OBI E E,LAKHANI B K,BURNS J,et al.Optic nerve sheath fenestration for idiopathic intracranial hypertension:A seven year review of visual outcomes in a tertiary centre[J].Clin Neurol Neurosurg,2015,137:94-101.